Clínica Baviera, S.A.

MCE CBAV.MC

Clínica Baviera, S.A. Interest Coverage Ratio for the year ending December 31, 2023: 87.88

Clínica Baviera, S.A. Interest Coverage Ratio is 87.88 for the year ending December 31, 2023, a -10.56% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Clínica Baviera, S.A. Interest Coverage Ratio for the year ending December 31, 2022 was 98.26, a 14.32% change year over year.
  • Clínica Baviera, S.A. Interest Coverage Ratio for the year ending December 31, 2021 was 85.95, a 124.17% change year over year.
  • Clínica Baviera, S.A. Interest Coverage Ratio for the year ending December 31, 2020 was 38.34, a 23.94% change year over year.
  • Clínica Baviera, S.A. Interest Coverage Ratio for the year ending December 31, 2019 was 30.94, a -70.09% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
SV Wall Street
MCE: CBAV.MC

Clínica Baviera, S.A.

CEO Mr. Eduardo Baviera Sabater
IPO Date April 3, 2007
Location Spain
Headquarters Paseo de la Castellana 20
Employees 1,326
Sector Consumer Discretionary
Industries
Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Similar companies

CAF.MC

Construcciones y Auxiliar de Ferrocarriles, S.A.

USD 36.52

0.39%

VID.MC

Vidrala, S.A.

USD 101.02

-0.16%

FAE.MC

Faes Farma, S.A.

USD 3.71

0.53%

MCM.MC

Miquel y Costas & Miquel, S.A.

USD 13.89

2.16%

AZK.MC

Azkoyen, S.A.

USD 6.58

-0.38%

StockViz Staff

February 7, 2025

Any question? Send us an email